MILESTONE SCIENTIFIC INC
MLSSNYSE AMERICANTrading Snapshot
- Day Range
- $0.32 β $0.32
- 52-Week Range
- $0.22 β $0.58
- Volume (shares)
- 5,700
- Avg Volume (shares)
- β
- Shares Outstanding
- 90.6M
- Next Earnings
- 2026-11-12
Fundamentals Snapshot
- Annual Revenue
- $9M
- Last Q Revenue
- $3M
- P/E Ratio
- -6.6
- P/S Ratio
- 3.0x
- EPS (TTM)
- $-0.04
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +2.8%
MILESTONE SCIENTIFIC INC
MLSSAbout MILESTONE SCIENTIFIC INC
Milestone Scientific Inc. is dedicated to the innovation, refinement, and global distribution of advanced diagnostic and therapeutic injection technologies and devices. These solutions cater to the medical, dental, and cosmetic industries, with a presence in the United States, China, and other international markets. The company's operations are divided into two main segments: Dental and Medical. Within its Dental division, key products include CompuDent and the STA Single Tooth Anesthesia System, both instrumental for delivering local anesthetics across all dental procedures. For broader applications, the firm offers CompuFlo, a sophisticated computer-controlled system capable of delivering drugs, anesthetics, and other medicaments comfortably and precisely, as well as aspirating bodily fluids or prior injections. Complementing this, a disposable injection handpiece provides precise tactile control during administration. In the Medical segment, Milestone Scientific introduces the CompuFlo Epidural, a computer-guided anesthesia system designed for a variety of medical applications. Additionally, their CompuMed system is utilized in numerous specialized procedures, including plastic surgery, hair restoration, colorectal surgery, podiatry, dermatology, and orthopedics, among others. Headquartered in Livingston, New Jersey, Milestone Scientific Inc. was established in 1989.
Otter Score Breakdown
How it's scoredFive components, each rated 1β5β and equally weighted (20%), averaged to a 0β100 score:π Quality β gross marginπ Growth β revenue YoYβοΈ Valuation β P/S ratioβ‘ Momentum β 30-day price changeπ§ Dilution β 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.